Leading Point-of-Care tests developer, which intends to help Chinese people cut healthcare cost by providing low-cost but high-quality in-vitro diagnostic tests to doctors, especially those at small hospitals and clinics. Starting from developing TB-Triple - the world-leading IVD test for Tuberculosis, BioHermes now aims to serve more people by expanding pipeline into Ob&G and Diabetes.
| Website | http://www.biohermes.cn |
| Employees | 13 (9 on RocketReach) |
| Founded | 2006 |
| Phone | +86 5108538589 |
| Technologies |
JavaScript
,
HTML
,
PHP
+4 more
(view full list)
|
| Industry | Medical Equipment Manufacturing |
| Keywords | Point Of Care Diagnostics, In Vitro Diagnostics, Medical Diagnostics, Ivd Tests, Diagnostic Testing, Healthcare Cost Reduction, Low Cost Diagnostics, High Quality Diagnostics, Infectious Disease Testing, Rapid Diagnostics, Clinical Diagnostics, Medical Devices, Affordable Healthcare, Poct Devices, Diagnostic Technology, Disease Detection, Health Technology, Medical Technology |
| Competitors | BASF, Ecolab, Evonik, CSL Behring, Novozymes, Codexis, Inc., Amyris, Geno, Zymergen, Inc., Archaeon Inc +49 more (view full list) |
Looking for a particular BioHermes employee's phone or email?
Kimi Luo is the Sales Director of BioHermes.
9 people are employed at BioHermes.